-The Telegraph Annual expenses for the government’s food security programme have been estimated at Rs 112,205 crore, which will make it very difficult for the government to fulfill its commitments on checking fiscal deficit. Food and consumers affairs minister K.V. Thomas disclosed the massive bill on the programme today in the Rajya Sabha, though no mention of this was made in Friday’s budget. Finance minister Pranab Mukherjee had just said he would foot...

Finance minister Pranab Mukherjee ushered in a regime of cash transfers for the payment of subsidies for food, fertilizers and kerosene, along with social welfare payments, by accepting the recommendations of a panel headed by Nandan Nilekani, chairman of the Unique Identification Authority of India. The recommendations, submitted last month, had prepared a blueprint for transferring cash directly into the bank accounts of the beneficiaries by linking these to their unique...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...

The latest round of data on the 2011 Census shows that the country is exhibiting distinct signs of trading up as material living conditions improve for large sections of the population. Although this aggregate picture is not uniform across the country, analysts believe that the upward material mobility in society is creating the basis of a new consumer boom in the economy—serving up a perfect backdrop ahead of the presentation of...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...